BioCorRx (BICX) Receivables - Net (2016 - 2025)
BioCorRx (BICX) has disclosed Receivables - Net for 15 consecutive years, with $253459.0 as the latest value for Q4 2025.
- Quarterly Receivables - Net changed N/A to $253459.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $253459.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $253459.0 for FY2025, 34151.22% up from the prior year.
- Receivables - Net hit $253459.0 in Q4 2025 for BioCorRx, up from $35000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $253459.0 in Q4 2025 to a low of $740.0 in Q4 2023.
- Historically, Receivables - Net has averaged $64915.4 across 4 years, with a median of $43310.0 in 2022.
- Biggest five-year swings in Receivables - Net: surged 2258.53% in 2022 and later tumbled 97.91% in 2023.
- Year by year, Receivables - Net stood at $1500.0 in 2021, then soared by 2258.53% to $35378.0 in 2022, then crashed by 97.91% to $740.0 in 2023, then surged by 34151.22% to $253459.0 in 2025.
- Business Quant data shows Receivables - Net for BICX at $253459.0 in Q4 2025, $35000.0 in Q3 2025, and $51242.0 in Q2 2025.